129 Results for "

PKC α

" in MedChemExpress (MCE) Product Catalog:
Products (129)

129 Results for "PKC α" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
86
86 Publications Verification
Cat. No.: HY-13689
CAS No.: 133053-19-7
Purity:  99.32%
Synonyms: Gö 6983; Goe 6983
Target:  

PKC

Research Areas:  

Cancer

Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ, PKCδ and PKCζ with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-13867
CAS No.: 133052-90-1
Purity:  98.15%
Synonyms: GF109203X; Go 6850
Target:  

PKC GSK-3

Research Areas:  

Metabolic Disease Cancer

Bisindolylmaleimide I (GF109203X) is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I is also a GSK-3 inhibitor .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-13867A
CAS No.: 176504-36-2
Purity:  99.18%
Synonyms: GF109203X hydrochloride; Go 6850 hydrochloride
Target:  

PKC GSK-3

Research Areas:  

Metabolic Disease Cancer

Bisindolylmaleimide I (GF109203X) hydrochloride is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I hydrochloride is also a GSK-3 inhibitor .
loading...
    loading...
39
39 Cited Publications
Cat. No.: HY-10230
CAS No.: 120685-11-2
Purity:  99.91%
Synonyms: PKC412; CGP 41251
Research Areas:  

Cancer

Midostaurin (PKC412; CGP 41251) is an orally active, reversible multi-targeted protein kinase inhibitor. Midostaurin inhibits PKCα/β/γ, Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFRβ and VEGFR1/2 with IC50s ranging from 22-500 nM . Midostaurin also upregulates endothelial nitric oxide synthase (eNOS) gene expression. Midostaurin shows powerful anticancer effects .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-10343
CAS No.: 425637-18-9
Purity:  99.79%
Synonyms: AEB071
Target:  

MARCKS PKC

Research Areas:  

Inflammation/Immunology Cancer

Sotrastaurin (AEB071) is a potent and orally-active pan-PKC inhibitor, with Kis of 0.22 nM, 0.64 nM, 0.95 nM, 1.8 nM, 2.1 nM and 3.2 nM for PKCθ, PKCβ, PKCα, PKCη, PKCδ and PKCε, respectively .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-18980
CAS No.: 82-08-6
Synonyms: Mallotoxin; NSC 56346; NSC 94525
Rottlerin, a natural product purified from Mallotus Philippinensis, is a specific PKC inhibitor, with IC50 values for PKCδ of 3-6 μM, PKCα,β,γ of 30-42 μM, PKCε,η,ζ of 80-100 μM. Rottlerin acts as a direct mitochondrial uncoupler, and stimulates autophagy by targeting a signaling cascade upstream of mTORC1. Rottlerin induces apoptosis via caspase 3 activation . Rottlerin inhibits HIV-1 integration and Rabies virus (RABV) infection .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-13866
CAS No.: 138489-18-6
Purity:  99.57%
Synonyms: Ro 31-8220 methanesulfonate; Bisindolylmaleimide IX mesylate
Target:  

PKC JNK

Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 mesylate can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-13866B
Synonyms: Bisindolylmaleimide IX formic
Target:  

PKC JNK

Research Areas:  

Cancer

Ro 31-8220 formic is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 formic also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively). Ro 31-8220 formic can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-10342
CAS No.: 170364-57-5
Purity:  99.92%
Synonyms: LY317615
Enzastaurin (LY317615) is a potent, selective, and CNS-penetrant PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-N0281
CAS No.: 486-35-1
Synonyms: 7,8-Dihydroxycoumarin
Daphnetin (7,8-dihydroxycoumarin), one coumarin derivative can be found in plants of the Genus Daphne, is a potent, oral active protein kinase inhibitor, with IC50s of 7.67 μM, 9.33 μM and 25.01 μM for EGFR, PKA and PKC in vitro, respectively. Daphnetin triggers ROS-induced cell apoptosis and induces cytoprotective autophagy by modulating the AMPK/Akt/mTOR pathway. Daphnetin has anti-inflammation activitity and inhibits TNF-α, IL-1β, ROS, and MDA production. Daphnetin has schizontocidal activity against malaria parasites. Daphnetin can be used for rheumatoid arthritis , cancer and anti-malarian research .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-100207
CAS No.: 125314-13-8
Purity:  99.74%
Synonyms: CP21
Target:  

GSK-3

Research Areas:  

Cancer

CP21R7 is potent GSK-3β inhibitor, with an IC50 of 1.8 nM; CP21R7 also shows inhibitory activitiy against PKCα, with an IC50 of 1900 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-117800
CAS No.: 1564249-38-2
Purity:  99.85%
Synonyms: B106
Target:  

PKC Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

BJE6-106 (B106) is a potent, selective 3 rd generation PKCδ inhibitor with an IC50 of 0.05 μM and targets selectivity over classical PKC isozyme PKCα (IC50=50 μM). BJE6-106 (B106) induces caspase-dependent apoptosis. BJE6-106 (B106) possesses tumor-specific effect.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B0719
CAS No.: 75567-37-2
Synonyms: Ingenol 3-angelate; PEP005
Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε, respectively, and has antiinflammatory and antitumor activity.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P0154
CAS No.: 182683-50-7
Synonyms: ε-V1-2; EAVSLKPT
Target:  

PKC

Research Areas:  

Inflammation/Immunology

Epsilon-V1-2 (ε-V1-2), a PKCε-derived peptide, is a selective PKCε inhibitor. Epsilon-V1-2 inhibits the translocationof PKCε, but not α-, β-, and δPKC .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-101569
CAS No.: 1874276-76-2
Purity:  99.42%
Synonyms: LXS196; IDE196
Target:  

PKC

Research Areas:  

Cancer

Darovasertib (LXS196) is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. Darovasertib has the potential for uveal melanoma research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-B1029
CAS No.: 17230-88-5
Target:  

PKC Apoptosis Tyrosinase

Research Areas:  

Endocrinology Cancer

Danazol inhibits the proliferation of cancer cell MDA-MB-231 and MCF-7 with IC50 of 65 µg/mL and 31 µg/mL. Danazol arrests the cell cycle at G1 phase, induces apoptosis in MDA-MB-231 through PKCα signaling pathway .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-103045
CAS No.: 865608-11-3
Purity:  98.95%
CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1 μM , 2.3 μM, 1.4 μM and 8.1 μM, respectively. CMPD101 can be used for the study of heart failure .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-126477
CAS No.: 64091-91-4
Purity:  99.98%
NNK is a nicotine-nitrosated derivative. NNK simultaneously stimulates Bcl2 phosphorylation exclusively at Ser 70 and c-Myc at Thr 58 and Ser 62 through activation of both ERK1/2 and PKCα . NNK induces survival and proliferation of human lung cancer cells. NNK can be used for lung cancer mice model structure .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-117610A
CAS No.: 145333-02-4
Purity:  ≥98.0%
Synonyms: Ro 32-0432; Ro 31-8830 hydrochloride
Target:  

PKC

Research Areas:  

Inflammation/Immunology

Bisindolylmaleimide XI hydrochloride (Ro 32-0432) is a potent, selective and orally active PKC inhibitor with IC50s of 9 nM, 28 nM, 31 nM, 37 nM, and 108 nM for PKCα, PKCβI, PKCβII, PKCγ, and PKCε, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18719A
CAS No.: 1032008-74-4
Endoxifen Z-isomer hydrochloride is an orally active selective PKCβ1 inhibitor with an IC50 of 360 nM against human PKCβ1. It also acts as an estrogen receptor modulator and antiestrogen. Endoxifen Z-isomer hydrochloride binds to and blocks ERα, ERβ and PKCβ1, inhibits estrogen and PI3K/AKT/mTORC1 signaling pathways, suppresses the expression of genes associated with cell cycle, cell proliferation and extracellular matrix remodeling, and induces apoptosis, reactive oxygen species (ROS) production and hypoxic features. Endoxifen Z-isomer hydrochloride inhibits tumor growth in breast tumor and glioblastoma models, reduces bone turnover and blood lipid levels, and does not require metabolism via CYP2D6. It can be used in research related to ER + breast cancer, invasive breast cancer, glioblastoma multiforme, type I bipolar disorder, desmoid tumor, gynecological malignancies, melanoma and hormone receptor-positive solid tumors .
loading...
    loading...